In this case study, an international ingredients company engaged CPL to look at a specific question relating to changes in legislation for herbal supplements as part of an acquisition process.
The client had heard that the regulatory environment was changing for herbal supplements and therefore wanted confirmation on how this would affect the market. CPL was able to answer their questions and also did this within a compressed timescale.
The objective of this study was first to assist the client in understanding regulatory changes in the market for herbal supplements and then assess the potential effects of these changes on the herbal supplement market. The client wanted details on the requirements of GAP and GMP legislation and also the timescales involved in meeting their standards.
CPL examined current European and US legislation and proposed legislation, and then conducted interviews with legislators and regulatory bodies. We also interviewed a US herbal manufacturer.
Click here for a PDF of the contents of the study or look below for an outline.
Herbal Supplements Legislation
- Principal Findings and Conclusions
- European Agency for the Evaluation of Medicinal Products
- European Union
- UN Food and Agriculture Organisation (FAO)
- Herbal Products Manufacturer
- Medicines Inspectorate
- US Food and Drug Administration (FDA)